Understanding how lung cells can regenerate after severe injury

Mesenchymal cell plasticity and signaling in lung regeneration

NIH-funded research University of Pennsylvania · NIH-10864439

This study looks at how lung cells heal after serious injuries like those from COVID-19 or the flu, and it aims to find new ways to help patients recover better and faster.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania NIH-funded
Lab location1 site (Philadelphia, United States)
Project IDNIH-10864439 on NIH RePORTER

What this research studies

This research investigates how lung cells respond to severe injuries, such as those caused by COVID-19 or influenza. It focuses on the different types of cells involved in lung regeneration and how they communicate with each other in the damaged area. By studying these processes, the research aims to identify new therapies that can promote effective lung healing and restore normal function. Patients who have experienced severe lung injuries may find this research particularly relevant as it seeks to improve recovery outcomes.

Who could benefit from this research

Good fit: Ideal candidates for this research are patients who have suffered severe lung injuries due to conditions like COVID-19 or influenza.

Not a fit: Patients with mild lung injuries or those who have not experienced significant respiratory distress may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance lung regeneration and improve long-term respiratory function for patients recovering from severe lung injuries.

How similar studies have performed: Other research has shown promise in understanding cell signaling and regeneration in various tissues, suggesting that this approach could yield valuable insights for lung healing.

Where this research is happening

Philadelphia, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.